Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.

Saved in:
Bibliographic Details
Title: Update on Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Authors: Achatz MI; Centro de Oncologia, Hospital Sírio-Libanês, Sao Paulo, Brazil., Villani A; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada., Bertuch AA; Pediatrics, Baylor College of Medicine, Houston, Texas., Bougeard G; Department of Genetics, Univ Rouen Normandie, Inserm U1245, Normandie Univ, CHU Rouen, Rouen, France., Chang VY; Pediatric Hematology-Oncology, University of California, Los Angeles, Los Angeles, California., Doria AS; Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.; Department of Medical Imaging, University of Toronto, Toronto, Canada., Gallinger B; Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Canada.; Department of Molecular Genetics, The University of Toronto, Toronto, Canada., Godley LA; Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Greer MC; Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.; Department of Medical Imaging, University of Toronto, Toronto, Canada., Kamihara J; Dana-Farber Cancer Institute, Boston, Massachusetts., Khincha PP; Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Kohlmann WK; VA Medical Center, National TeleOncology Program, Clinical Cancer Genetics Service, Durham, North Carolina.; University of Utah Huntsman Cancer Institute, Salt Lake City, Utah., Kratz CP; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany., MacFarland SP; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Maese LD; University of Utah-Huntsman Cancer Institute, Primary Children's Hospital, Salt Lake City, Utah., Maxwell KN; Department of Medicine-Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Medicine Service, Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania., Mitchell SG; Department of Pediatric Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia., Nakano Y; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada., Pfister SM; Division Pediatric Neurooncology, Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg University Hospital and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Wasserman JD; Division of Endocrinology, The Hospital for Sick Children, Toronto, Canada.; Department of Paediatrics, University of Toronto, Toronto, Canada., Woodward ER; Faculty of Biology, Medicine and Health, University of Manchester, Manchester Centre for Genomic Medicine, Manchester, United Kingdom., Garber JE; Division of Cancer Genetics and Prevention, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Malkin D; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Canada.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 May 15; Vol. 31 (10), pp. 1831-1840.
Publication Type: Consensus Statement; Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-24-3301